Oda M - Search Results

1

Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.

Takehara A, Kawakami K, Ohta N, Oyama K, Ota Y, Oda M, Watanabe G. Takehara A, et al. Among authors: oda m. Anticancer Res. 2005 Nov-Dec;25(6C):4455-61. Anticancer Res. 2005. PMID: 16334126 Free article.

2

Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.

Tamura M, Ohta Y, Tsunezuka Y, Matsumoto I, Kawakami K, Oda M, Watanabe G. Tamura M, et al. Among authors: oda m. J Thorac Cardiovasc Surg. 2005 Sep;130(3):740-5. doi: 10.1016/j.jtcvs.2004.12.051. J Thorac Cardiovasc Surg. 2005. PMID: 16153922 Free article.

3

In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.

Takizawa M, Kawakami K, Obata T, Matsumoto I, Ohta Y, Oda M, Sasaki T, Watanabe G. Takizawa M, et al. Among authors: oda m. Oncol Rep. 2006 Jun;15(6):1533-9. Oncol Rep. 2006. PMID: 16685392

4

Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.

Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, Ota Y, Oda M, Watanabe G. Ota N, et al. Among authors: oda m. Anticancer Res. 2006 Sep-Oct;26(5B):3729-32. Anticancer Res. 2006. PMID: 17094392 Free article.

5

Vascular endothelial growth factor expression in airways of patients with lung cancer: a possible diagnostic tool of responsive angiogenic status on the host side.

Ohta Y, Ohta N, Tamura M, Wu J, Tsunezuka Y, Oda M, Watanabe G. Ohta Y, et al. Among authors: oda m. Chest. 2002 May;121(5):1624-7. doi: 10.1378/chest.121.5.1624. Chest. 2002. PMID: 12006453

6

Results of recent therapy for non-small-cell lung cancer with brain metastasis as the initial relapse.

Ohta Y, Oda M, Tsunezuka Y, Uchiyama N, Nishijima H, Takanaka T, Ohnishi H, Kohda Y, Yamashita J, Watanabe G. Ohta Y, et al. Among authors: oda m. Am J Clin Oncol. 2002 Oct;25(5):476-9. doi: 10.1097/00000421-200210000-00011. Am J Clin Oncol. 2002. PMID: 12393988

7

Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis; clinicopathologic features and patterns of nodal spread.

Watanabe S, Oda M, Tsunezuka Y, Go T, Ohta Y, Watanabe G. Watanabe S, et al. Among authors: oda m. Eur J Cardiothorac Surg. 2002 Dec;22(6):995-9. doi: 10.1016/s1010-7940(02)00578-x. Eur J Cardiothorac Surg. 2002. PMID: 12467826

8

Peripherally located occult lung cancer with AMFR expression.

Tamura M, Ohta Y, Oda M, Watanabe G. Tamura M, et al. Among authors: oda m. Ann Thorac Cardiovasc Surg. 2003 Jun;9(3):184-7. Ann Thorac Cardiovasc Surg. 2003. PMID: 12875641

9

Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer.

Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Ohta Y, Watanabe G. Tamura M, et al. Among authors: oda m. Chest. 2004 Aug;126(2):342-6. doi: 10.1378/chest.126.2.342. Chest. 2004. PMID: 15302715

10

The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.

Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G. Tamura M, et al. Among authors: oda m. Ann Surg Oncol. 2004 Oct;11(10):928-33. doi: 10.1245/ASO.2004.01.013. Epub 2004 Sep 20. Ann Surg Oncol. 2004. PMID: 15383417 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,041 results

Search Page

Filters